Trials / Completed
CompletedNCT00264966
Multiple Dose ASM8 in Mild Asthmatics
A Double-blind, Placebo-controled, Crossover Study To Evaluate the Efficacy, Safety and Tolerability of Inhaled ASM8-003 in Subjects With Mild Allergic Asthma.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 15 (planned)
- Sponsor
- Syntara · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety and efficacy of multiple doses of ASM8 antisense oligonucleotides in asthmatics.
Detailed description
This is a double-blind, placebo-controlled, crossover trial to evaluate the safety, tolerability and efficacy of inhaled ASM8 for the treatment of allergen-induced asthma. Individuals with stable, mild to moderate allergic asthma by American Thoracic Society (ATS) criteria (1), with a history of episodic wheeze and shortness of breath, will be eligible for enrolment. The study is divided into 2 parts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASM8 |
Timeline
- Start date
- 2005-12-01
- Completion
- 2006-04-01
- First posted
- 2005-12-13
- Last updated
- 2012-12-03
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00264966. Inclusion in this directory is not an endorsement.